SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950123-01-502827
Filing Date
2001-05-21
Accepted
2001-05-21 00:00:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D y49434sc13d.txt SC 13D 33844
2 AGREEMENT AND PLAN OF MERGER y49434ex99-a.txt EX-99.A 234575
3 FORM OF VOTING AND STOCK OPTION AGREEMENTS y49434ex99-b.txt EX-99.B 41734
  Complete submission text file 0000950123-01-502827.txt   312431
Mailing Address ONE MERCK DR PO BOX 100 WS3AB-05 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DR P O BOX 100 WHITEHOUSE STATION NJ 08889-0100 9084234044
MERCK & CO INC (Filed by) CIK: 0000064978 (see all company filings)

IRS No.: 221109110 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12040 115TH AVENUE NE KIRKLAND WA 98034
Business Address 12040 115TH AVE NE SUITE 210 KIRKLAND WA 98034 4258237336
ROSETTA INPHARMATICS INC (Subject) CIK: 0001081935 (see all company filings)

IRS No.: 911770023
Type: SC 13D | Act: 34 | File No.: 005-59447 | Film No.: 1644634
SIC: 8731 Services-Commercial Physical & Biological Research